找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Difficult To Treat Asthma; Clinical Essentials Sandhya Khurana,Fernando Holguin Book 2020 Springer Nature Switzerland AG 2020 asthma.diffic

[復(fù)制鏈接]
查看: 29566|回復(fù): 56
樓主
發(fā)表于 2025-3-21 19:46:23 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Difficult To Treat Asthma
副標(biāo)題Clinical Essentials
編輯Sandhya Khurana,Fernando Holguin
視頻videohttp://file.papertrans.cn/279/278974/278974.mp4
概述Details difficult to treat asthma, its difference from severe asthma, and clinical management guidelines.Contains clinical pearls from leading asthma experts that can be used as a quick bedside refere
叢書名稱Respiratory Medicine
圖書封面Titlebook: Difficult To Treat Asthma; Clinical Essentials Sandhya Khurana,Fernando Holguin Book 2020 Springer Nature Switzerland AG 2020 asthma.diffic
描述This book provides a practical, stepwise, evidence-based approach to effective management of patients with difficult to treat asthma. The impact of asthma on morbidity and healthcare utilization increases exponentially with severity. Severe refractory asthma accounts for less than 5% of all asthma. Its prevalence, however, is often overestimated as there are several other confounding factors that make asthma ‘difficult to treat’. Many novel (albeit expensive) therapies are now available and providers caring for patients with severe asthma are charged with selecting the best evidence treatment. This calls for complex and nuanced decision-making. Whether people with asthma gain and maintain control over their condition depends not only on the availability of effective drugs, but also multiple patient and healthcare provider behaviors. Therefore, now more than ever, it has become increasingly important to differentiate “difficult” from “severe refractory” asthma to allow identification of patients most likely to benefit from these therapies.?.?.This volume delves into the current understanding of mechanisms and increasingly recognized heterogeneity of this complex disease. It discusse
出版日期Book 2020
關(guān)鍵詞asthma; difficult asthma; severe asthma; refractory asthma; uncontrolled asthma; persistent asthma
版次1
doihttps://doi.org/10.1007/978-3-030-20812-7
isbn_softcover978-3-030-20814-1
isbn_ebook978-3-030-20812-7Series ISSN 2197-7372 Series E-ISSN 2197-7380
issn_series 2197-7372
copyrightSpringer Nature Switzerland AG 2020
The information of publication is updating

書目名稱Difficult To Treat Asthma影響因子(影響力)




書目名稱Difficult To Treat Asthma影響因子(影響力)學(xué)科排名




書目名稱Difficult To Treat Asthma網(wǎng)絡(luò)公開度




書目名稱Difficult To Treat Asthma網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Difficult To Treat Asthma被引頻次




書目名稱Difficult To Treat Asthma被引頻次學(xué)科排名




書目名稱Difficult To Treat Asthma年度引用




書目名稱Difficult To Treat Asthma年度引用學(xué)科排名




書目名稱Difficult To Treat Asthma讀者反饋




書目名稱Difficult To Treat Asthma讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:36:52 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:50:42 | 只看該作者
地板
發(fā)表于 2025-3-22 06:58:08 | 只看該作者
5#
發(fā)表于 2025-3-22 10:28:29 | 只看該作者
Heterologous Protein Expression by ,o objective testing, a thorough consideration of these conditions should be undertaken both at the time of initial asthma diagnosis and again in any asthma patient whose disease is unresponsive to therapy or difficult to control.
6#
發(fā)表于 2025-3-22 16:34:09 | 只看該作者
7#
發(fā)表于 2025-3-22 17:04:10 | 只看該作者
Tanja Holland,Johannes Felix Buyel clinical characteristics. Understanding heterogeneity will lead to improved understanding of the pathophysiology underpinning the clinical presentation. However, future work will need to focus on characterizing subtypes of severe asthma in a fashion that has direct relevance for treatment and outcomes.
8#
發(fā)表于 2025-3-22 22:18:25 | 只看該作者
9#
發(fā)表于 2025-3-23 02:39:18 | 只看該作者
https://doi.org/10.1007/978-3-319-96202-3ly true for difficult or severe asthma. A high-risk asthma service can provide patients with state-of-the-art, evidence-based clinical management. This chapter provides an overview of complexities of “difficult-to-control” asthma and a practical systematic approach to its management.
10#
發(fā)表于 2025-3-23 08:31:49 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-6 13:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
尚义县| 安福县| 江津市| 剑河县| 灵武市| 泽普县| 新绛县| 和田市| 定安县| 玉树县| 兴宁市| 双辽市| 建昌县| 乌拉特前旗| 泸州市| 东源县| 桓台县| 新民市| 宝兴县| 林口县| 石嘴山市| 岚皋县| 沂源县| 永登县| 读书| 安新县| 长葛市| 乌审旗| 梅州市| 三亚市| 伊宁市| 和静县| 奈曼旗| 桦川县| 南昌市| 大足县| 江达县| 涞源县| 永济市| 家居| 黄骅市|